David A. Siegel Insmed Inc Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Insmed Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 716,400 shares of INSM stock, worth $48 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
716,400
Previous 629,200
13.86%
Holding current value
$48 Million
Previous $19.5 Million
0.32%
% of portfolio
0.05%
Previous 0.05%
Shares
27 transactions
Others Institutions Holding INSM
# of Institutions
339Shares Held
141MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$972 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$791 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$722 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$396 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$321 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.08B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...